Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility...
CNBC’s Jim Cramer applauded Monday’s market gains for Big Tech, which had seen a sell-off in the early days of the new year as Wall Street...
Bristol-Myers Squibb CEO Chris Boerner detailed the pharmaceutical giant’s bundle of recent acquisitions in a Monday interview with CNBC’s Jim Cramer, and indicated the company is...
CNBC’s Jim Cramer on Friday pointed out the number of biopharma mergers and acquisitions that have closed or been announced over the last few months. He...
CNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan‘s market-moving health-care conference in San Francisco. Taking place...
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in...
Check out the companies making headlines in midday trading. Intel — The semiconductor stock added 4.6% after Israel’s government announced a $3.2 billion grant. The grant...
Our 10 things to watch Tuesday, Dec. 26 1. Stocks rose slightly to kick off the final trading week of the year, as longer-dated bonds pull...
Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018. Regis Duvignau...
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed...
